Skip to main content Skip to footer

Welcome to Orexo US, Inc.

We work to bring innovative treatment solutions to patients in the United States.

Who We Are

  • We are Orexo’s US operation, and we are integral to bringing innovative treatment solutions to patients in the United States.
  • Our organization is focused on commercializing ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII) in the US market.
  • We also offer digital mental health programs designed to help patients with Opioid Use Disorder (OUD), alcohol management, and depression.
  • We have a strong, experienced US Leadership Team.

Who We Serve

  • Patients with opioid dependence or OUD
  • Patients with addiction, alcohol abuse, or depression
  • Patients with mental illnesses looking to increase their access to healthcare

Orexo Digital Health Disclaimers

MODIA is not a healthcare provider and does not provide medical advice, diagnosis, or specific treatment, and is marketed under FDA enforcement discretion.

Vorvida is marketed as a general wellness product. Vorvida is not a healthcare provider and does not provide medical advice, diagnosis, or treatment.

Deprexis is not a healthcare provider and does not provide medical advice, diagnosis, or standalone treatment, and is marketed under FDA enforcement discretion.